Puberty-blocking linked with fewer suicides in transgender people
But only a small fraction of interested children receive the therapy, say researchers
Transgender youth who receive puberty-blocking medicines may lower their suicide risk, a US study suggests.
Researchers examined survey data from 20,619 transgender adults, aged 18-36, who described their current mental health, as well as any interest in puberty suppression when they were younger.
